MegaRed Extra Strength
Natural health product licensed in Canada
- Licence holder
- Reckitt Benckiser (Canada) Inc.
- NPN or DIN-HM
- 80044740
- Status
- Active licence
- Licence date
- 16 September 2013
- Revision date
- 10 December 2014
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- TPD Cat IV/LS
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Sorbitol, Gélatine, Ethyl Vanillin, Glycérine, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of Omega-3 fatty acids (DHA/EPA) for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Megared has been shown to significantly increase your Omega-3 Index, a marker of cardiovascular health, in just 6 weeks. In conjunction with conventional statin therapy and maintenance of healthy diet, helps to reduce the levels of serum triglycerides / triacylglycerols and LDL cholesterol, and to increase the levels of HDL cholesterol in patients with hyperlipidemia; take 4 capsules daily. Clinically shown to help maintain / support cardiovascular health. To help reduce pain associated with osteoarthritis and to help reduce C reactive protein levels, a clinical marker of inflammation. Helps to relieve symptoms of dysmenorrheal and premenstrual syndrome, take 4 capsules daily.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80044740
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging